» Articles » PMID: 30304517

Characterization of Cell Fusion in an Experimental Mouse Model of Endometriosis†

Overview
Journal Biol Reprod
Date 2018 Oct 11
PMID 30304517
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Cell fusion is involved in the development of some adult organs, is implicated in the pathogenesis of specific types of cancer, and is known to participate in repair/regeneration processes mediated by bone-marrow-derived cells (BMDCs). Endometriosis is a disease characterized by growth of functional endometrial tissue outside of the uterine cavity. Endometriosis shares some molecular properties with cancer and BMDCs home to endometriosis lesions in a mouse model. Our objective was to determine if cell fusion can occur in endometriosis and establish whether bone-marrow-derived cells participate in cell fusion events in lesions. We employed a Cre-Lox system to identify cell fusion events in a mouse model of endometriosis. Fused cells were detected in endometriotic lesions, albeit at a low frequency (∼1 in 400 cells), localized to the stromal compartment, and displayed restricted proliferation. Using 5-fluorouracil-based nongonadotoxic bone marrow transplantation model, we demonstrate that bone marrow cells represent a principal cell source for fusion events in lesions. Cell fusion progeny uniformly lacked expression of selected markers of hematopoietic, endothelial, and epithelial markers, though they expressed the mesenchymal/stromal markers Sca-1 and CD29. This study is the first to describe the phenomenon of cell fusion in endometriosis and points to a mesenchymal population derived from cell fusion events with limited proliferative activity, properties previously attributed to endometrial stem cells. Their putative role in the pathogenesis of the disease remains to be elucidated.

Citing Articles

Cell Fusion and Syncytia Formation in Cancer.

Sieler M, Dittmar T Results Probl Cell Differ. 2023; 71:433-465.

PMID: 37996689 DOI: 10.1007/978-3-031-37936-9_20.


Generation of Cancer Stem/Initiating Cells by Cell-Cell Fusion.

Dittmar T Int J Mol Sci. 2022; 23(9).

PMID: 35562905 PMC: 9101717. DOI: 10.3390/ijms23094514.


Endometriosis in the Mouse: Challenges and Progress Toward a 'Best Fit' Murine Model.

Burns K, Pearson A, Slack J, Por E, Scribner A, Eti N Front Physiol. 2022; 12:806574.

PMID: 35095566 PMC: 8794744. DOI: 10.3389/fphys.2021.806574.


Cancer Cell Fusion and Post-Hybrid Selection Process (PHSP).

Hass R, von der Ohe J, Dittmar T Cancers (Basel). 2021; 13(18).

PMID: 34572863 PMC: 8470238. DOI: 10.3390/cancers13184636.


Hybrid Formation and Fusion of Cancer Cells In Vitro and In Vivo.

Hass R, von der Ohe J, Dittmar T Cancers (Basel). 2021; 13(17).

PMID: 34503305 PMC: 8431460. DOI: 10.3390/cancers13174496.


References
1.
Platt J, Zhou X, Lefferts A, Cascalho M . Cell Fusion in the War on Cancer: A Perspective on the Inception of Malignancy. Int J Mol Sci. 2016; 17(7). PMC: 4964493. DOI: 10.3390/ijms17071118. View

2.
Cervello I, Martinez-Conejero J, Horcajadas J, Pellicer A, Simon C . Identification, characterization and co-localization of label-retaining cell population in mouse endometrium with typical undifferentiated markers. Hum Reprod. 2006; 22(1):45-51. DOI: 10.1093/humrep/del332. View

3.
Sakr S, Naqvi H, Komm B, Taylor H . Endometriosis impairs bone marrow-derived stem cell recruitment to the uterus whereas bazedoxifene treatment leads to endometriosis regression and improved uterine stem cell engraftment. Endocrinology. 2014; 155(4):1489-97. PMC: 3959601. DOI: 10.1210/en.2013-1977. View

4.
Thomsen L, Schnack T, Buchardi K, Hummelshoj L, Missmer S, Forman A . Risk factors of epithelial ovarian carcinomas among women with endometriosis: a systematic review. Acta Obstet Gynecol Scand. 2016; 96(6):761-778. DOI: 10.1111/aogs.13010. View

5.
Nisolle M, Donnez J . Coexpression of cytokeratin and vimentin in eutopic endometrium and endometriosis throughout the menstrual cycle: evaluation by a computerized method. Fertil Steril. 1995; 64(1):69-75. View